IR Contact
| Primary IR Contact |
| Gregory Gin Email: ir@edgetherapeutics.com |
| Primary IR Contact |
| Gregory Gin Email: ir@edgetherapeutics.com |
Precisa™, our proprietary, programmable, biodegradable polymer-based development platform, enables creation of polymer-based therapeutics capable of delivering directly to the site of injury.
Read More
Our lead product candidate, EG-1962, is a polymer-based microparticle containing nimodipine developed with the Precisa platform to improve patient outcomes after Aneurysmal Subarachnoid Hemorrhage.
Read More
